RETA

Reata Pharmaceuticals Inc

No insider bought or sold Reata Pharmaceuticals Inc in the last 12 months

$0Bought, 12 mo

$0Sold, 12 mo

Follow RETA

RETA over the last year

Prices for RETA aren't in yet.

RETA after insider buys

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

121 insider filings since 2016, newest first

RETASell

Andrea Loewen · SVP, Global Regulatory Affairs

$546K−10.0%Sep 18

RETASell

Bhaskar Anand · SVP and Chief Accounting Officer

$69K−2.0%Sep 7

RETASell

Michael D Wortley · General Counsel

$204K−2.0%Aug 17

RETASell

Manmeet Singh Soni · COO, CFO and President

$296K−3.0%Aug 17

RETASell

Colin John Meyer · Chief Innovation Officer

$463K−3.0%Aug 17

RETASell

Dawn Carter Bir · Chief Commercial Officer

$203K−3.0%Aug 17

RETASell

Bhaskar Anand · SVP and Chief Accounting Officer

$68K−2.0%Aug 17

RETASell

Manmeet Singh Soni · COO, CFO and President

$12.3M−54.0%Aug 1

RETASell

Shamim Ruff · Director

$1.4M−53.0%Aug 1

RETASell

William D. Mcclellan Jr. · Director

$822K−45.0%Aug 1

RETASell

Dawn Carter Bir · Chief Commercial Officer

$6.6M−53.0%Aug 1

RETASell

Bhaskar Anand · SVP and Chief Accounting Officer

$239K−9.0%Jun 16

RETASell

Manmeet Singh Soni · COO, CFO and President

$8.5M−59.0%Jun 14

RETASell

Michael D Wortley · General Counsel

$110K−3.0%May 17

RETASell

Manmeet Singh Soni · COO, CFO and President

$1.9M−16.0%May 17

RETASell

Colin John Meyer · Chief Innovation Officer

$527K−7.0%May 17

RETASell

Samina Khan · SVP and Chief Medical Officer

$53K−2.0%May 17

RETASell

Bhaskar Anand · SVP and Chief Accounting Officer

$93K−4.0%May 17

RETASell

Dawn Carter Bir · Chief Commercial Officer

$110K−4.0%May 17

RETASell

Andrea Loewen · SVP, Global Regulatory Affairs

$616K−18.0%May 16

RETASell

Dawn Carter Bir · Chief Commercial Officer

$808K−22.0%Mar 15

RETASell

Shamim Ruff · Director

$481K−52.0%Mar 13

RETASell

Andrea Loewen · SVP, Global Regulatory Affairs

$1.6M−33.0%Mar 9

RETASell

Dawn Carter Bir · Chief Commercial Officer

$8.5M−70.0%Mar 8

RETASell

Colin John Meyer · Chief Innovation Officer

$53K−1.0%Mar 8

RETASell

Manmeet Singh Soni · COO, CFO and President

$53K−1.0%Mar 8

RETASell

Michael D Wortley · General Counsel

$35K−1.0%Mar 8

RETASell

Samina Khan · SVP and Chief Medical Officer

$331K−9.0%Mar 8

RETASell

Colin John Meyer · Chief Innovation Officer

$8.1M−52.0%Mar 6

RETASell

Michael D Wortley · General Counsel

$190K−4.0%Mar 6

RETASell

Manmeet Singh Soni · COO, CFO and President

$316K−4.0%Mar 6

RETASell

Andrea Loewen · SVP, Global Regulatory Affairs

$160K−4.0%Mar 6

RETASell

Samina Khan · SVP and Chief Medical Officer

$2.4M−39.0%Mar 6

RETASell

Bhaskar Anand · SVP and Chief Accounting Officer

$72K−3.0%Mar 6

RETASell

Dawn Carter Bir · Chief Commercial Officer

$191K−4.0%Mar 6

RETASell

James Warren Huff · CEO

$6.4M−59.0%Mar 3

RETABuy

Manmeet Singh Soni · COO and CFO

$420K+533.0%Jan 4

RETASell

Colin John Meyer · Chief Research Officer

$8.6M−78.0%Jun 16

RETASell

Elaine Castellanos · VP and Chief Accounting Officer

$1.4M−41.0%Jun 9

RETASell

Elaine Castellanos · VP and Chief Accounting Officer

$1.2M−41.0%May 27

RETASell

Colin John Meyer · Chief Research Officer

$4.2M−26.0%Nov 18

RETASell

William D. Mcclellan Jr. · Director

$692K−100.0%Nov 13

RETASell

Elaine Castellanos · VP and Chief Accounting Officer

$616K−19.0%Nov 13

RETASell

Michael D Wortley · General Counsel

$9.2M−100.0%Nov 12

RETASell

Colin John Meyer · Chief Research Officer

$4.4M−26.0%Nov 10

RETASell

William D. Mcclellan Jr. · Director

$600K−100.0%Nov 10

RETASell

James Warren Huff · CEO

$14.3M−74.0%Nov 10

RETASell

Dawn Carter Bir · Chief Commercial Officer

$9.8M−100.0%Nov 10

RETABuy

Manmeet Singh Soni · COO and CFO

$301KAug 14

RETASell

Elaine Castellanos · VP and Chief Accounting Officer

$288K−12.0%Jun 1

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.